Cystic echinococcosis (CE), caused by the parasite Echinococcus granulosus, is a prominent disease in Lebanon. The objectives of this study were to determine HLA allele-CE association in patients, and relate its presence to high anti-Echinococcus antibody titers and the presence of circulating immune complexes (CIC). Thirty patients and 20 controls were included. HLA profiles were determined by DNA-SSP typing. Relative risk and P-values were determined for each allele using Statcalc (EpiInfo, Version 6). Linkage disequilibrium was determined for associated alleles using SPSS 12.0 for Windows. Antibody titers were determined by indirect hemagglutination (IHA) and CIC by polyethylene glycol (PEG) precipitation. HLA-B*14 and HLA-DRB1*01 appeared to associate with protection against CE (P1 = P2 = 0.007 and P1 = P2 = 0.0007, respectively). However, it appeared that linkage disequilibrium did not exist between these 2 alleles (P = 0.250). HLA-B*35 was found to associate with susceptibility to disease (RR = 1.70, P = 0.02). Twenty five patients had anti-Echinococcus antibodies and 9 patients had CICs. However, there did not appear to be a correlation between the presence of HLA-B*35 and high antibody titers, or the presence of CICs. In conclusion, 2 HLA alleles that associate with resistance and 1 that associates with susceptibility to E. granulosus infection have been identified. The joint pain reported by some of the patients might be attributed to CIC deposits.
Introduction
Cystic echinococcosis (CE) (or hydatid disease) is a prominent cyclozoonotic disease of the Mediterranean basin, including Lebanon, caused by the cestode parasite Echinococcus granulosus (Awn 1986 , Gottstein 1992 , Eckert and Deplazes 2004 . The parasite's definitive host, a carnivore, is most commonly the domestic dog or other canids, while the intermediate host could be sheep, pigs, the cattle or camels (Zhang et al. 2003, Eckert and Deplazes 2004) . Humans are accidental hosts, not usually involved in the regular life cycle of the cestode. Intermediate and accidental hosts are often symptomatic, contrary to the case of the definitive host.
The host immune status appears to control the susceptibility to, or resistance against the parasite (Kanaan 1984 , Gottstein 2003 . Evidence suggests that production of a Th1 immune response confers protection against E. granulosus while a Th2 immune response is suggestive of susceptibility to CE (Hernandez et al. 1999 , Zhang et al. 2003 , Rigano et al. 2004 . Specific and polyclonal activation of B-lymphocytes occurs in hydatid disease. Nevertheless, humoral immunity does not appear to play a protective role (D'Amelio et al. 1983 , Kanaan 1984 .
MHC molecules or HLA, expressed by Antigen Processing/Presenting Cells, are involved in presenting peptides to Tlymphocytes (Klein and Sato 2000) . Moreover, a number of HLA alleles have been reported to be associated with the occurrence of CE (Shcherbakov and Monje-Barredo 1989; Shcherbakov 1993; Azab et al. 2004a, b) . On the other hand, some HLA alleles were reported to associate with protection from the E. granulosus parasite (Shcherbakov and MonjeBarredo 1989, Shcherbakov 1993) .
Circulating immune complexes (CIC) at times are produced as a consequence to an infectious disease (Raja et al. 2002 , Ohsawa et al. 2003 . These complexes could be pathological if they deposit at various anatomical sites. CIC have been detected in patients with malaria, trypanosomosis, schistosomosis, toxoplasmosis and hydatid disease (D'Amelio et al. 1983 (D'Amelio et al. , 1989 Van Knapen et al. 1985; Wozencraft et al. 1990; Gottstein 1992) . In an earlier study done in our laboratory, CICs were detected in 70% of CE patients (Kanaan 1984) . Moreover, Gottstein (1992) reported the presence of CIC in 33 to 85% of CE patients.
Since HLA-disease associations might vary among ethnic groups, the objectives of this study were to determine HLA allele-CE associations in Lebanese patients, and if susceptibility associated allele is identified, determine if its presence correlated with high anti-Echinococcus antibody titer and the presence of circulating immune complexes.
Materials and methods

Patients and controls
Thirty patients were randomly selected and diagnosed with cystic echinococcosis based on clinical, imaging and serological results. The control group included 20 randomly selected individuals, none of which had CE at the time of the study.
All participating patients and controls were included in the study after their full written consent. Case history was collected from all patients and the following information was recorded: patient's age, gender, residence, lifestyle, locality of hydatid cyst and presence of joint pain (Table I) .
Blood specimens and processing
Blood was collected in citrated and plain vacutainers from the 30 patients and the 20 controls.
Serum was separated from the clotted blood in the plain tube and stored at -20°C until used for the detection of circulating immune complexes (CIC) and anti-Echinococcus antibody levels.
The buffy coat from the centrifuged citrated blood was transferred to a 1.5 ml microcentrifuge tube. DNA was extracted from the buffy coat using the scalable method of the GFX™ Genomic Blood DNA Purification Kit (Amersham Biosciences, GE Healthcare, Uppsala, Sweden) according to the manufacturer's description. The concentration of the recovered DNA was subsequently measured using an Ultrospec 1000E spectrophotometer (Pharmacia Biotech, Uppsala, Sweden). The extracted DNA was stored at -20°C until used for the determination of HLA profiles.
Determination of HLA profiles by DNA typing
The One Lambda (Canoga Park, CA) polymerase chain reaction-sequence specific primer (PCR-SSP) technique was used. Class I (A, B and C) and Class II (DR and DQ) alleles were determined for all patients and controls. Amplicons were detected by gel electrophoresis and visualized under ultraviolet light using an Ultralum Dual light transilluminator (Carson, CA). Gels were photographed with a Polaroid camera (Polaroid, UK) and a black and white Polaroid film type 667 (Polaroid, UK).
Determination of anti-Echinococcus antibody titers
Indirect hemagglutination (IHA) titers were determined using the Cellognost*-Echinococcosis kit (Dade Behring, Marburg GmbH, Germany). According to the IHA kit manufacturer, a mid-range titer is between 1:512 and 1:2048. Titers greater than 1:2048 are considered high. The antigen used for the procedure was the Cellognost*-Echinococcosis reagent (echinococcosis IHA reagent) provided with the kit, a lyophilized reagent with E. granulosus antigen from human hydatid fluids.
Detection of circulating immune complexes (CIC)
Polyethylene glycol (PEG) precipitation was performed for the detection of CIC in the sera of patients. Nine parts of 4.166% polyethylene glycol in borate buffer were added to 1 part of a 1:3 dilution of serum to be tested. The whole mixture was vortexed and incubated for one hour at room temperature. Absorbances were read using a Thermo Spectronic Biomate 3 spectrophotometer at a wavelength of 450 nm. Borate buffer was used as a blanking solution. Any absorbance difference (∆ absorbance) result above 0.23 was considered positive (Riha et al. 1979 , Abdelnoor et al. 2004 .
Determination of HLA allele-CE association
Relative risk (RR) and P-values (P) were calculated for the 30 patients and 20 controls using Statcalc (EpiInfo Version 6) program. An allele was considered to associate with susceptibility to disease, when its relative risk was greater than 1 with a significant P-value (P # 0.05). An allele was considered to associate with protection when the P-value was significant (P # 0.05), its RR non-defined by the program in this instance.
When more than one allele on different loci were shown to significantly associate with susceptibility to, or protection against CE, linkage disequilibrium (LD) calculation was performed to see whether these alleles occurred on the same chro- ∆ (A, B) = observed frequency -expected frequency = frequency AB -frequency A × frequency B P-values were calculated for ratios of (frequency AB/frequency A -frequency B) greater than 1, using SPSS 12.0 for
Windows to check the significance of these ratios. P # 0.05 was considered significant.
Results
HLA-CE associations
HLA-B*14 and HLA-DRB1*01 were considered to associate with protection against CE as they were only noted in the control population with undefined relative risks (Statcalc program ignored the relative risk in the case of protective alleles). The Fisher exact 1-and 2-tailed P-values for HLA-B*14 and HLA-DRB1*01 alleles were P1 = P2 = 0.007 and P1 = P2 = 0.0007, respectively. On the other hand, HLA-B*35 was considered to associate with susceptibility to CE. The relative risk in relation to disease was equal to 1.70 with a significant P-value of 0.02 (Table II) .
No linkage disequilibrium existed between HLA-B*14 and HLA-DRB1*01 alleles, as shown by the obtained P-value equal to 0.250, a value that is greater than 0.05, thus considered insignificant.
When looking at HLA profiles of patients with multiple organ involvement, in particular the lungs and the liver, data showed that out of 9 individuals with multiple organ infection, 7 were HLA-B*35 positive.
Anti-Echinococcus antibody titers and HLA-B*35-positive patients
Antibody titers obtained, ranged from 1:16 to higher than 1:16,384 (Table IIIa) . All controls had antibody titers of less than 1:16. Five of nine patients with low titers, 3 of 7 with moderate titers and 6 of 9 with high titers were HLA-B*35-positive.
Circulating immune complexes and HLA-B*35-positive patients
Five of 9 CIC-positive patients and 9 of 21 CIC-negative patients were HLA-B*35-positive. Seven of 30 patients complained of joint pain, 3 of whom were CIC-positive (Table  IIIb) .
Discussion
The determination of an HLA allele-disease association is based on the frequency of an allele in the normal population and that in the diseased population, both populations belonging to the same ethnic group and subject to similar infection risk. Various ethnic groups have been studied to determine HLA associations for a number of diseases, and different HLA alleles have been reported for the same disease. HLA-A10, HLA-B5 and HLA-B18 have been reported to associate with susceptibility to cystic echinococcosis (Shcherbakov 1993) . A study dealing with the Egyptian population, reported the association of HLA-DR3 and HLA-DR11 with CE, complicated cases being mostly related to HLA-DR3 (Azab et al. 2004a, b) . These differences could be due, in part to variation in allele frequencies among ethnic groups. In one study, we reported that the frequency of HLA-B27 in Lebanese was less than that in European Caucasians and suggested that the strong association between HLA-B27 and ankylosing spondilitis in European Caucasians might not hold true for Lebanese. The lack of an association in Lebanese was later confirmed (Abdelnoor et al. 1985 (Abdelnoor et al. , 2000 . In Lebanese patients, HLA-B*35 allele, appeared to associate with susceptibility to CE. Concurring with our results, Shcherbakov and MonjeBarredo (1989) reported in a Russian article that HLA-B35 antigen was associated with susceptibility, however, to alveolar echinococcosis (AE). An attempt to find HLA-B*35 frequency in the normal Russian population was not successful since all articles were in Russian. However, reports have shown HLA-B35 antigen to be widely present in different Russian ethnicities (Rychkov and Udina 1985 , Abramov et al. 1990 , Udina and Rautian 1994 as well as associated with a number of diseases in Russians (Pevnitskiy et al. 1989 , Popov et al. 2005 .
The finding that HLA-B*14 allele associated with protection against E. granulosus, was in accordance with reports showing that HLA-B14 antigen associated with resistance to CE (Shcherbakov and Monje-Barredo 1989, Shcherbakov 1993) . As for HLA-DRB1*01, there are no previous reports on its relation with resistance to E. granulosus. It could therefore be an allele, associating with protection against CE, specifically in the Lebanese population.
Some patients with CE do not develop antibodies. Some explanations for the absence of antibodies are: the cyst is calcified and no longer immunogenic, the patient is immunosuppressed, or there is no leakage of antigen from the cyst to induce an immune response (Araj 1973, Eckert and Deplazes 2004) . No or low responses could be related to an HLA allele. Therefore, an attempt was made to determine if there was an association between HLA-B*35 and anti-Echinococcus antibody levels and/or the presence of CIC. It can be seen from Table IIIa that the number of HLA-B*35 positive patients in relation to high antibody titer is approximately similar to that in relation with low titer. Likewise, it can be seen in Table IIIb that the number of HLA-B*35 positive patients in relation to the presence of CIC is approximately similar to that in relation to the absence of CIC. Hence, such associations do not appear to exist.
The presence of CIC could have serious consequences. If they deposit in the kidneys, they will cause glomerulonephritis and in the joints, arthritis. Sanchez et al. (1983) reported on the relation of CE with bouts of arthritic disease. Anti-Echinococcus antibodies in synovial fluid and complement deposits in the joints were detected. Three CIC-positive patients in the present study had joint pain, possibly due to deposition of CIC in the joints. On the other hand, none of the patients had glomerulonephritis.
In conclusion, HLA alleles associating to both resistance and susceptibility have been identified. However, no correlation appeared to exist among the susceptible HLA-B*35 allele, high antibody titers, and the presence of CIC.
